100% to funding lifesaving cancer research at Fred Hutch—that’s the short answer. Here’s the more detailed one.
Fred Hutchinson Cancer Research Center is a world renowned, independent research center focused on the elimination of cancer and related diseases as causes of human suffering and death. Fred Hutch conducts research of the highest standards to improve prevention and treatment of cancer and related diseases. Cancer research comprises a large portion of the work happening here. The research spans many cancer types while also digging deep into specific cancer areas—thereby revealing commonalities, dissimilarities and striking insights with life-saving implications. This holistic approach truly distinguishes Fred Hutch.
Since the inaugural Obliteride event in August 2013, Obliteride funds have been directly applied to prostate cancer, immunotherapy and pediatric brain cancer research. As with other privately funded research at Fred Hutch—meaning funding not from government and grants—some funds from Obliteride are being distributed to the research projects with the most promising and the most imminent insights. Some of these could explore the connection between lifestyle and cancer, while others could accelerate the understanding and use of umbilical cord transplantation, a method discovered at the Hutch that shows promise as a more flexible, less toxic alternative to bone marrow transplantation for treating many types of cancers.
Given that Fred Hutch is solely focused on research, every dollar donated through Obliteride is fueling understanding and accelerating lifesaving discoveries that translate to improved patient care through our Seattle Cancer Care Alliance (SCCA) partners and cancer-care organizations around the world.